ClinicalTrials.gg
RecruitingNCT03880344Updated Dec 7, 2023

Investigating the Effectiveness of Vibration Therapy on Sarcopenia in Osteoarthritis Knee Patients

An interventional study of Vibration Therapy and Physiotherapy in Knee Arthropathy, Osteoarthritis, Knee and Knee Osteoarthritis, sponsored by Chinese University of Hong Kong. Recruiting at 1 site in Hong Kong. Open to participants aged 45 Years and older. Per ClinicalTrials.gov, last updated 2023-12-07.

Sponsored by Chinese University of Hong Kong · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 10 months ago, but the record still lists the study as recruiting.
  • Started Jan 2020; still recruiting 6 years 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
45 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 20 studies in Osteoarthritis, Knee by Chinese University of Hong Kong — 9 open to participants now, 10 under way, none of them phase 3. Osteoarthritis, Knee · Chinese University of Hong Kong.

Planned enrollment
13th of 16
50 · median 64
Started
2020
with 3 others
No phase
15 of 20
8 open now
Registered
2nd of 20
by date

Among the 20 studies in Osteoarthritis, Knee by Chinese University of Hong Kong, this one is the 13th largest by planned enrollment of the 16 interventional ones that give a count, is one of 4 that started in 2020, is one of 15 with no phase, and was the 2nd registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

9 of the 20 studies in Osteoarthritis, Knee by Chinese University of Hong Kong are open now, in 1 country. Recruiting first, the newest first:

3 more — sign in →

By country, each count listing its studies:

All 9 open studies →

Where they have run

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 45 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 20 studies in Osteoarthritis, Knee by Chinese University of Hong Kong, or all of them as a file.
02

Study summary

Osteoarthritis (OA) is one of the commonest chronic degenerative conditions affecting our aging population. It limits joint movement and causing disability in elderlies due to discordant symptoms such as pain and stiffness. The prevalence of radiologic knee osteoarthritis increases in proportion to age, reaching an astounding 64.1% for patients whom are over 60 years of age. In addition the prevalence of symptomatic knee OA has been shown to be around 10% in people who are 60 years and older.

Read the detailed description

Patients with end stage OA often adopt a sedentary lifestyle causing mobility and functionality decline to avoid joint pain and stiffness. This dysfunctions a series of antioxidant response cascades which eventually leads to muscle atrophy of the knee. Notably, muscle atrophy and weakness (i.e. sarcopenia) often accompanies with OA. However the relationship between these symptoms and OA remains undefined and no strong consensus have been made thus far. Our ongoing longitudinal study on muscle strength and functionality which investigates the prevalence of sarcopenia in end stage OA patient's pre and post operation (Total Knee Replacement) have reflected that 24% with severe knee OA patients also suffered sarcopenia. In addition, these patients also showed a much slower recovery and longer length of stay in hospital after undergoing surgical operation.

The effect of clinical sarcopenia affects our locomotion system in the aging population. Weakness in patients and decline in muscle strength results in significant functional impairment are often seen in the cohort, leading to fragility, falls, fractures and disability.

Many authors have tried to explain the pathophysiology of sarcopenia in an attempt to link the disorder to a molecular or biochemical level in numerous literature. Satellite cells (a myogenic stem cell), Insulin like growth factor 1 (IGF-1) (an important mediator of muscle growth and regeneration affecting muscle function) and fast twitch muscle fibres are three major molecular composites that have been widely studied. Evidence have suggested the close relationship between them and muscle atrophy and weakness. However, these studies have either shown the results from an animal standpoint or they lack specificity and further research is necessary to confirm their role in patients suffering from sarcopenia.

Attempts have also been made to discover the most effective intervention to treat or even eliminate the chances of sarcopenia. Among these studies resistance exercises have been documented the most.

Evidence showed that progressive resistance and aerobic exercises are most beneficial for the prevention and treatment of sarcopenia. Resistant training that such as lifting weights, strength resistance bands, resistance machines has shown to improve protein synthesis in skeletal muscle cells leading to better muscle strength and mass, leading to muscle hypertrophy and promotes muscle power. Our previous knowledge transfer study on developing an aerobic exercise (i.e. Tai Chi Exercise) for end stage OA patients also showed similar positive effects in subjects, decreasing their pain and stiffness symptoms and limitations in physical activity. Though resistance exercise showed promising effects, are safe and strongly advised interventions based on documented and our previous study, the elderly populations often accompanies with other physical symptoms (such as back pain) and diminished fine motor skills that may limit their range of movement in these exercise regimes. In addition, resistive exercises are extremely technical and is essential to execute with proper form to avoid further injury; hence these exercises are unable to perform safely alone at home, making the intervention less autonomous.

Vibration therapy is a noninvasive biophysical modality and has been demonstrated in a number of studies showing multiple positive effects in terms of postural control, balancing ability, circulation and most importantly muscle strength. Two of our previous studies investigated the long term effects on muscle performance and bone quality in using low-magnitude high frequency vibration. Though the results showed that the treatment is an effective method in fall prevention by improving on both frontiers, these two studies' main subject focuses were on the elderly population as a whole. A study pivoting on subjects with co-existing diagnosis of sarcopenia and OA is crucial to investigate the effectiveness of this therapy method. Limited studies have shown positive effects of vibration therapy on osteoarthritis, however, these studies were limited to a single gender (i.e. females) or contained subject recruitment bias or assessment period of less than 6 months. A randomized control trial with a longer assessment period is essential to investigate the true effects of vibration therapy on knee OA patients.

03

Conditions studied

  • Knee Arthropathy
  • Osteoarthritis, Knee
  • Knee Osteoarthritis

Keywords

  • vibration therapy
  • Knee Osteoarthritis
  • Knee Arthropathy
04

Who can participate

Ages eligible
45 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male and female patients aged over 45 with end stage knee OA
  • Patient has been scheduled for TKR
  • Able to comply with the assessments and has given oral and written consent

Exclusion criteria

Exclusion Criteria:

  • Patients with connective tissue disorders or myositis condition
  • Previous cases of alcoholism or drug abuse
  • Pregnancy or breast feeding
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Care provider, Investigator, Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Vibration Therapy + Normal Out-Patient Physiotherapy

    Patients' randomized to this group will receive vibration therapy as a pre-operative rehabilitation programme 3 times a week for 3 months. Regular out-patient department physiotherapy will also be given. They will be assessed 6 weeks and 6 months post operatively.

    Device: Vibration Therapy · Combination Product: Physiotherapy

  • Active comparator
    Normal Out-Patient Department Physiotherapy

    Patients randomized to this group will receive regular out-patient department physiotherapy postoperatively for 6 months. They will be assessed 6 weeks and 6 months post operatively.

    Combination Product: Physiotherapy

Interventions

  • DeviceVibration Therapy

    Vibration therapy as a pre-operative rehabilitation programme 3 times a week for 3 months + Normal Regular out-patient department physiotherapy

  • Combination productPhysiotherapy

    Physiotherapy as post-operative rehabilitation programme for 6 months.

06

What researchers measure

Primary outcomes

  1. Knee Flexion/Extension Strength

    Muscle strength on the quadriceps is measured by instructing the patient to perform an active knee flexion/extension movement in a sitting position with both feet free from ground, and the hip and knee joint flexed at 90%. The optimal isometric force of the knee flexion/extension movement are measured by the dynamometer attached at the malleoli level with a strap. The measurements (0 to 30 cm) will be taken at maximum force for three times.

    Time frame: Baseline Assessment

  2. Knee Flexion/Extension Strength

    Muscle strength on the quadriceps is measured by instructing the patient to perform an active knee flexion/extension movement in a sitting position with both feet free from ground, and the hip and knee joint flexed at 90%. The optimal isometric force of the knee flexion/extension movement are measured by the dynamometer attached at the malleoli level with a strap. The measurements (0 to 30 cm) will be taken at maximum force for three times.

    Time frame: Pre-Operative Assessment

  3. Knee Flexion/Extension Strength

    Muscle strength on the quadriceps is measured by instructing the patient to perform an active knee flexion/extension movement in a sitting position with both feet free from ground, and the hip and knee joint flexed at 90%. The optimal isometric force of the knee flexion/extension movement are measured by the dynamometer attached at the malleoli level with a strap. The measurements (0 to 30 cm) will be taken at maximum force for three times.

    Time frame: Post-Operative 6 weeks

  4. Knee Flexion/Extension Strength

    Muscle strength on the quadriceps is measured by instructing the patient to perform an active knee flexion/extension movement in a sitting position with both feet free from ground, and the hip and knee joint flexed at 90%. The optimal isometric force of the knee flexion/extension movement are measured by the dynamometer attached at the malleoli level with a strap. The measurements (0 to 30 cm) will be taken at maximum force for three times.

    Time frame: Post-Operative 6 months

  5. Knee Flexion/Extension Strength

    Muscle strength on the quadriceps is measured by instructing the patient to perform an active knee flexion/extension movement in a sitting position with both feet free from ground, and the hip and knee joint flexed at 90%. The optimal isometric force of the knee flexion/extension movement are measured by the dynamometer attached at the malleoli level with a strap. The measurements (0 to 30 cm) will be taken at maximum force for three times.

    Time frame: Post-Operative 12 months

Secondary outcomes

  1. Whole body lean muscle mass

    DXA measurement scan

    Time frame: Baseline Assessment

  2. Whole body lean muscle mass

    DXA measurement scan

    Time frame: Pre-Operative Assessment

  3. Whole body lean muscle mass

    DXA measurement scan

    Time frame: Post-Operative 6 months

  4. Muscle Biopsy

    Types of muscle fibers and satellite cells as Assessed by Muscle Biopsy Assessment

    Time frame: Intra-Operatively

  5. Knee Functions measure by the Knee Society Score

    Physician will assess on the Visual Analog Scale in pain score (None to Severe), Flexion Contracture (None to \>20°), Extension lag (None to 20°), Total Range of Flexion (0-5° to 121-125°), Alignment (0° to Over 15°), Antero-posterior stability (\<5mm to 10+mm), Mediolateral stability (\<5° to 15°). Patients will record individuals' satisfaction, functional activities, and expectations.

    Time frame: Baseline Assessment

  6. Knee Functions measure by the Knee Society Score

    Physician will assess on the Visual Analog Scale in pain score (None to Severe), Flexion Contracture (None to \>20°), Extension lag (None to 20°), Total Range of Flexion (0-5° to 121-125°), Alignment (0° to Over 15°), Antero-posterior stability (\<5mm to 10+mm), Mediolateral stability (\<5° to 15°). Patients will record individuals' satisfaction, functional activities, and expectations.

    Time frame: Pre-Operative Assessment

  7. Knee Functions measure by the Knee Society Score

    Physician will assess on the Visual Analog Scale in pain score (None to Severe), Flexion Contracture (None to \>20°), Extension lag (None to 20°), Total Range of Flexion (0-5° to 121-125°), Alignment (0° to Over 15°), Antero-posterior stability (\<5mm to 10+mm), Mediolateral stability (\<5° to 15°). Patients will record individuals' satisfaction, functional activities, and expectations.

    Time frame: Post-Operative 6 weeks

  8. Knee Functions measure by the Knee Society Score

    Physician will assess on the Visual Analog Scale in pain score (None to Severe), Flexion Contracture (None to \>20°), Extension lag (None to 20°), Total Range of Flexion (0-5° to 121-125°), Alignment (0° to Over 15°), Antero-posterior stability (\<5mm to 10+mm), Mediolateral stability (\<5° to 15°). Patients will record individuals' satisfaction, functional activities, and expectations.

    Time frame: Post-Operative 6 months

  9. Knee Functions measure by the Knee Society Score

    Physician will assess on the Visual Analog Scale in pain score (None to Severe), Flexion Contracture (None to \>20°), Extension lag (None to 20°), Total Range of Flexion (0-5° to 121-125°), Alignment (0° to Over 15°), Antero-posterior stability (\<5mm to 10+mm), Mediolateral stability (\<5° to 15°). Patients will record individuals' satisfaction, functional activities, and expectations.

    Time frame: Post-Operative 12 months

  10. Knee Function measures by 6 meter Timed Walking Gait Test

    The 10 meter timed walking test is a well-established and documented test for assessment for gait speed in patients. However, due to space limitations and the exhaustive nature of the test for patients with OA, the 6 meter test has been documented to be a valid and reliable substitute. Patients will be asked to walk a straight line of 6 meters where the time taken to complete the distance will be measured. (\<7.5 seconds is normal).

    Time frame: Baseline Assessment

  11. Knee Function measures by 6 meter Timed Walking Gait Test

    The 10 meter timed walking test is a well-established and documented test for assessment for gait speed in patients. However, due to space limitations and the exhaustive nature of the test for patients with OA, the 6 meter test has been documented to be a valid and reliable substitute. Patients will be asked to walk a straight line of 6 meters where the time taken to complete the distance will be measured. (\<7.5 seconds is normal).

    Time frame: Pre-Operative Assessment

  12. Knee Function measures by 6 meter Timed Walking Gait Test

    The 10 meter timed walking test is a well-established and documented test for assessment for gait speed in patients. However, due to space limitations and the exhaustive nature of the test for patients with OA, the 6 meter test has been documented to be a valid and reliable substitute. Patients will be asked to walk a straight line of 6 meters where the time taken to complete the distance will be measured. (\<7.5 seconds is normal).

    Time frame: Post-Operative 6 weeks

  13. Knee Function measures by 6 meter Timed Walking Gait Test

    The 10 meter timed walking test is a well-established and documented test for assessment for gait speed in patients. However, due to space limitations and the exhaustive nature of the test for patients with OA, the 6 meter test has been documented to be a valid and reliable substitute. Patients will be asked to walk a straight line of 6 meters where the time taken to complete the distance will be measured. (\<7.5 seconds is normal).

    Time frame: Post-Operative 6 months

  14. SF-12

    The 36-Item Short Form Health Survey (SF-12) will be used to measure the health related Quality of Life. The SF-12 has twelve questions ; the scores are weighted sums of the questions in each section. Scores range from 0 - 60. Lower scores = more disability, higher scores = less disability.

    Time frame: Baseline Assessment

  15. SF-12

    The 36-Item Short Form Health Survey (SF-12) will be used to measure the health related Quality of Life. The SF-12 has twelve questions ; the scores are weighted sums of the questions in each section. Scores range from 0 - 60. Lower scores = more disability, higher scores = less disability.

    Time frame: Pre-Operative Assessment

  16. SF-12

    The 36-Item Short Form Health Survey (SF-12) will be used to measure the health related Quality of Life. The SF-12 has twelve questions ; the scores are weighted sums of the questions in each section. Scores range from 0 - 60. Lower scores = more disability, higher scores = less disability.

    Time frame: Post-Operative 6 weeks

  17. SF-12

    The 36-Item Short Form Health Survey (SF-12) will be used to measure the health related Quality of Life. The SF-12 has twelve questions ; the scores are weighted sums of the questions in each section. Scores range from 0 - 60. Lower scores = more disability, higher scores = less disability.

    Time frame: Post-Operative 6 months

  18. Western Ontario and McMaster University Osteoarthritis Index (WOMAC)

    The WOMAC will be used as a self-administered health status measure in assessing pain, stiffness, and function in patients with OA of the hip or knee. Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.

    Time frame: Baseline Assessment

  19. Western Ontario and McMaster University Osteoarthritis Index (WOMAC)

    The WOMAC will be used as a self-administered health status measure in assessing pain, stiffness, and function in patients with OA of the hip or knee. Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.

    Time frame: Pre-Operative Assessment

  20. Western Ontario and McMaster University Osteoarthritis Index (WOMAC)

    The WOMAC will be used as a self-administered health status measure in assessing pain, stiffness, and function in patients with OA of the hip or knee. Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations. With a scale ranges from 0 to 96. Lower scores = more disability, higher scores = less disability.

    Time frame: Post-Operative 6 weeks

  21. Western Ontario and McMaster University Osteoarthritis Index (WOMAC)

    The WOMAC will be used as a self-administered health status measure in assessing pain, stiffness, and function in patients with OA of the hip or knee. Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations. With a scale ranges from 0 to 96. Lower scores = more disability, higher scores = less disability.

    Time frame: Post-Operative 6 months

  22. IPAQ

    The 36-Item Short Form Health Survey (SF-12) will be used to measure health-related physical activity (PA) performance. With a scale ranges from 0 to 96. Lower scores = more disability, higher scores = less disability.

    Time frame: Baseline Assessment

  23. IPAQ

    The 36-Item Short Form Health Survey (SF-12) will be used to measure health-related physical activity (PA) performance. Score is expressed as MET-min per week: MET level x minutes of activity x events per week. Computed to fall into the category of: "Low", "Moderate" and "High" level of Physical Activity.

    Time frame: Pre-Operative Assessment

  24. IPAQ

    The 36-Item Short Form Health Survey (SF-12) will be used to measure health-related physical activity (PA) performance. Score is expressed as MET-min per week: MET level x minutes of activity x events per week. Computed to fall into the category of: "Low", "Moderate" and "High" level of Physical Activity.

    Time frame: Post-Operative 6 weeks

  25. IPAQ

    The 36-Item Short Form Health Survey (SF-12) will be used to measure health-related physical activity (PA) performance. Score is expressed as MET-min per week: MET level x minutes of activity x events per week. Computed to fall into the category of: "Low", "Moderate" and "High" level of Physical Activity.

    Time frame: Post-Operative 6 months

  26. Hand-grip Strength

    Average of 3 times hand-grip strength values measures by a hand dynamometer grip strength meter.

    Time frame: Baseline Assessment

  27. Hand-grip Strength

    Average of 3 times hand-grip strength values measures by a hand dynamometer grip strength meter.

    Time frame: Pre-Operative Assessment

  28. Hand-grip Strength

    Average of 3 times hand-grip strength values measures by a hand dynamometer grip strength meter.

    Time frame: Post-Operative 6 weeks

  29. Hand-grip Strength

    Average of 3 times hand-grip strength values measures by a hand dynamometer grip strength meter.

    Time frame: Post-Operative 6 months

  30. Gait Speed

    6 meter timed walking gait test

    Time frame: Baseline Assessment

  31. Gait Speed

    6 meter timed walking gait test

    Time frame: Pre-Operative Assessment

  32. Gait Speed

    6 meter timed walking gait test

    Time frame: Post-Operative 6 weeks

  33. Gait Speed

    6 meter timed walking gait test

    Time frame: Post-Operative 6 months

07

Study locations

1 of 1 sites recruiting
  • Department of Orthopaedics & Traumatology
    Hong Kong, Hong Kong
    Recruiting
    • Ki Wai Ho, MBChB, MSc, MRCSEd, FRCSEd · Contactkevinho@cuhk.edu.hk · (852) 3505 2715
    • Ki Wai Ho, MBChB, MSc, MRCSEd, FRCSEd · Principal investigator
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2020 (actual). Primary completion is estimated for Dec 2024, 59 months after the start.

Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 59 months is above that.

Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 6, 2019
First posted
Mar 19, 2019
StartActual
Jan 31, 2020
Primary completionEst.
Dec 31, 2024
CompletionEst.
Dec 31, 2024
Last update
Dec 7, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 7, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03880344
Responsible party
Dr. Ho Ki Wai (Clinical Professional Consultant, Chinese University of Hong Kong) — Principal investigator
First posted
Mar 19, 2019
Start date
Jan 31, 2020
Primary completion
Dec 31, 2024 (estimated)
Completion
Dec 31, 2024 (estimated)
Last update
Dec 7, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion